FDA Adverse Event Other Summary report: N

RELIEVA STRATUS MICROFLOW SPACER

MDR report key: 1531409 · Received November 12, 2009

Report

Report Number
3005172759-2009-00004
Event Type
Other
Date Received
November 12, 2009
Date of Event
October 9, 2009
Report Date
November 9, 2009
Manufacturer
ACCLARENT, INC.
Product Code
KAM
PMA / PMN Number
K062458
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS NOT AVAILABLE FOR RETURN. THE LOT NUMBER OF THE FRONTAL SPACER, (B)(4), WAS REVIEWED. A REVIEW OF THE DEVICE HISTORY RECORD AND HISTORICAL TRENDING WAS PERFORMED. THE PRODUCT MET SPEC. WE WILL CONTINUE TO INVESTIGATE THIS COMPLAINT, IF THERE IS ANY RELEVANT INFO FOUND, A SUPPLEMENTAL MEDWATCH FORM WILL BE FILED.

Description of Event or Problem · 1

THIS EVENT OCCURRED IN ONE PT. ON (B)(6) 2009, THE PT HAD FUNCTIONAL ENDOSCOPIC SINUS SURGERY, IN WHICH BALLOON SINUSPLASTY DEVICES WERE USED TO DILATE BOTH FRONTAL SINUSES, ALONG WITH BILATERAL FRONTAL SINUS SPACER IMPLANTATION. ON (B)(6) 2009, 34 DAYS LATER, THE PHYSICIAN ATTEMPTED TO REMOVE THE FRONTAL SINUS SPACERS IN OFFICE, BUT WAS UNABLE TO VISUALIZE THEM. THE FRONTAL SPACER IFU IS ONLY APPROVED FOR 14 DAY IMPLANTATION. ON (B)(6) 2009, DAY 38, THE PT WAS TAKEN TO THE OPERATING ROOM TO REMOVE THE FRONTAL SPACERS UNDER FLUOROSCOPY. THE RIGHT FRONTAL SPACER WAS REMOVED WITHOUT ISSUE. THE LEFT WAS ALSO REMOVED, BUT WAS FOUND TO BE MISSING ONE OF THE RETENTION WINGS. THE RETENTION WING IS A SMALL COMPONENT OF THE SPACER MADE OF NITINOL. THIS COMPONENT IS L-SHAPED IN APPEARANCE, MADE FROM WIRE MEASURING .2 MM IN DIAMETER. AFTER FURTHER EXPLORATION DURING THE SAME SURGICAL PROCEDURE, THE DETACHED RETENTION WING WAS RETRIEVED. ON (B)(6) 2009, THE PHYSICIAN REPORTED THAT THE PT WAS DOING WELL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 RELIEVA STRATUS MICROFLOW SPACER STRATUS FRONTAL SPACER KAM ACCLARENT, INC. 090504A

Patients

Seq Age Sex Outcome Treatment
1 51 YR Hospitalization| R